Insulin aspart protamine and insulin aspart Subcutaneous and Tofacitinib Citrate
Determining the interaction of Insulin aspart protamine and insulin aspart Subcutaneous and Tofacitinib Citrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart protamine and insulin aspart Subcutaneous-Tofacitinib Extended-Release Tablets
- Insulin aspart protamine and insulin aspart Subcutaneous-Tofacitinib Tablets
- Insulin aspart protamine and insulin aspart Subcutaneous-Tofranil
- Insulin aspart protamine and insulin aspart Subcutaneous-Tofranil injection
- Insulin aspart protamine and insulin aspart Subcutaneous-Tofranil-PM
- Insulin aspart protamine and insulin aspart Subcutaneous-Tol-Tab
- Tofacitinib Citrate-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Tofacitinib Citrate-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Tofacitinib Citrate-Insulin Aspart Protamine Injection
- Tofacitinib Citrate-Insulin aspart, recombinant Subcutaneous
- Tofacitinib Citrate-Insulin degludec
- Tofacitinib Citrate-Insulin Degludec (U-100) Prefilled Pens